Press releases found on our website are intended as reference information for investors and journalists. The information contained in each press release was accurate at the time of issuance and caprotec™ bioanalytics GmbH assumes no responsibility for updating the information to reflect subsequent developments.

• caprotec bioanalytics announces the successful completion of a collaborative research project with Roche

Berlin, Germany and Burlington, MA, June 28, 2010 - caprotec bioanalytics GmbH announced today that it has succesfully completed a research collaboration with F. Hoffmann-La Roche, Basel, Switzerland. Under the collaboration research agreement, caprotec used its proprietary CCMS (Capture Compound Mass Spectrometry) technology to analyze the binding characteristics and interaction of one undisclosed drug candidate with its human target proteins.
Download

• caprotec bioanalytics Completes Series B Financing Round of EUR 4 Million

Berlin, Germany and Burlington, MA, May 13, 2010 - caprotec bioanalytics GmbH today announced the closing of a EUR 4 million ($5.1M) Series B Financing Round with existing investors Creathor Venture, IBB Beteiligungsgesellschaft, ERP Startfonds, and well-known private investors. The proceeds will enable further development and marketing of the Company´s proprietary CCMS (Capture Compound Mass Spectrometry) platform technology for analyzing complex protein mixtures.
Download

• caprotec bioanalytics Announces Commercial Launch Of Three New caproKits™ For Applications In Proteomics And Drug Development

Berlin, Germany and Burlington, MA, January 26, 2010 - caprotec bioanalytics GmbH anounced today the commercial launch of three new caporKits™, enabling the discovery, identification and characterization of proteins belonging to the group of metallo-proteases, histon-deacetylases and GDP/GTP binding proteins.
Download

• Germany-based caprotec bioanalytics opens US Subsidiary in Burlington, Massachusetts; Appoints President

Burlington, MA, and Berlin, Germany, November 19, 2009 - caprotec bioanalytics GmbH ammounced today the opening of its US subsidiary based in Burlington, MA. caprotec Inc. will be responsible for North American sales, marketing and support of caprotec´s proprietary Capture Compound Mass Spectrometry (CCMS) technology and its related products.
Download

• caprotec bioanalytics announces launch of new Stauro caproKit™ for signal transduction research and drug development

Berlin, Germany, May 13, 2009 - caprotec bioanalytics GmbH announced today the commercial launch of its Stauro caproKit™, enabling the discovery, identification and characterization of proteins interacting with staurosporine.
Download

• caprotec bioanalytics announces the appointment of Funakoshi as distributor for its products on the Japanese market

Berlin, Germany, February 09, 2009 - caprotec bioanalytics GmbH announced today that they entered into an exclusive distributorship agreement with Funakoshi Co. Ltd. for the marketing and sales of caprotec´s research products in the country of Japan.
Download

• caprotec bioanalytics announces launch of new products for research and drug development

Berlin, Germany, January 19, 2009 - caprotec bioanalytics GmbH announced today that they completed the commercial launch of their first two caproKits™.
Download

• caprotec bioanalytics awarded 0,6 m € grant for research and development

Berlin, Germany, December 15, 2008 – caprotec bioanalytics GmbH announced today that they won a grant of up to 0,6 m € over a period of 2 years.
Download

• caprotec bioanalytics adds two patents to its significant patent estate

Berlin, Germany, December 2, 2008 – caprotec bioanalytics GmbH announced today that the Canadian Patent Office hase granted two Canadian patents covering the company's revolutionary Capture Compound Mass Spectrometry (CCMS) technology.
Download

• caprotec bioanalytics and Merck KGaA Sign Collaboration Agreement

Berlin, Germany, May 28, 2008 – caprotec bioanalytics GmbH announced today that they have signed a collaboration agreement with Merck KGaA acting for its division Merck Serono.
Download

• caprotec bioanalytics GmbH Appoints Dr. Mathias Grote as Chief Financial and Chief Operating Officer

Berlin, Germany, March 13, 2008 – caprotec bioanalytics GmbH announced today the appointment of Dr. Mathias Grote as Chief Financial Officer and Chief Operating Officer of the Company.
Download

• Life Science Startup caprotec bioanalytics Receives Additional Venture Capital Funding

Berlin, Germany, January 10, 2008 – caprotec bioanalytics GmbH receives a total of EUR 6 million ($8.8M) in two rounds of financing.
Download

• caprotec bioanalytics obtains € 4.5M (ca. $6.5M) Startup financing

Berlin, Germany, November 22, 2007 – caprotec bioanalytics GmbH has obtained capital investments.
Download